We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Billam | LSE:BLLM | London | Ordinary Share | GB00B06CZD75 | ORD 0.1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 0.75 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
Hot Features
Premium
RNS Number : 8943X
Billam PLC
30 June 2008
Preliminary Results
BILLAM PLC: PRELIMINARY RESULTS FOR THE YEAR ENDED 31 DECEMBER 2007
The Board of Billam PLC ("Billam" or "the Company") today announces its preliminary results for the year ended 31 December 2007.
Key Points:
* Wholly owned subsidiary, Development Funding Limited ("DFL") has invested £1.05 million by way of mezzanine finance to a
housebuilder.
* Loss on ordinary activities before taxation reduced to £0.837 million (2006: £0.912 million)
* Net asset value per share 6.6p (2006:13.9p)
Commenting on the results, Simon Bennett, Chairman of Billam said:
"We continue to review our investment portfolio and will continue to look for opportunities to make realisations as and when we can
achieve valuations that meet our expectations. We are cautious about the outlook of DFL's business in the current economic climate and will
look to take advantage of attractive opportunities for the longer term."
For further information contact:
Simon Bennett 0207 598 5368
Nish Malde 01923 713600
_________________________________________________________________________ _____
CHAIRMAN'S STATEMENT
______________________________________________________________________________< /fipP>
As shareholders will be aware there has been much talk in the press of the effects on the world economy created by the so called credit
crunch. There can be little doubt that we will continue to see the effects of the credit crunch on both the world and the UK economy for
sometime to come.
PERFORMANCE DURING THE YEAR
The Board announce that the loss on ordinary activities before taxation has been reduced to £0.8 million (2006: loss £0.9 million) but
we are disappointed to note that Billam's net assets have now fallen to £0.7 million (2006: £1.5 million). Of the loss on ordinary
activities £0.6 million is due to the further reduction in the value of Billam's investment portfolio, further details of which are set out
below. Whilst this is unsatisfactory we do not have any control over the share price performance of our investee companies and shareholders
should bear in mind that the performance of smaller company shares in the last 12 months has generally been poor.
The Directors do not intend to recommend the payment of a dividend.
We have four investments in our portfolio, three are listed on the Alternative Investment Market ("AIM") and one, TRI-MEX Group Limited
is an unquoted private company. We have also invested in our wholly owned development finance subsidiary, Development Funding Limited
("DFL"). I would like to draw your attention to the achievements of our specific investee companies, as follows:-
AIM LISTED INVESTMENTS
Cybit Holdings plc
Cybit Holdings plc ("Cybit") is one of Europe's leading telematics service providers, that provides organisations with a comprehensive
suite of online solutions to improve the management and control of their mobile assets. Cybit operates within three distinct sectors,
namely: internet based vehicle telematics solutions; economic exclusion zone management and private mobile radio based asset tracking and
precise positioning management.
In its latest interim results, for the 6 months ended 30 September 2007 Cybit announced some good results with turnover up 55 per cent
at £9.0 million (2006: turnover £5.8 million), operating profits of £1.23 million (2006: operating profit £0.52 million) and profits before
taxation up to £616,000 compared to £19,000 for the comparative period.
In terms of the future growth opportunities the Directors of Cybit consider that whilst the UK, the company's principal place of
operations, is an established market, the rates of penetration into the UK commercial vehicle telematics sector are estimated to be no more
than 3 per cent. Cybit estimates that they have a 20 per cent market share of those units currently installed and that they are therefore
well placed to exploit the opportunities that are available to them.
Since these results were announced in December, 2007 Cybit has announced a number of new business wins, contract renewals and contract
extensions with such companies as: the online groceries business of Sainsbury's; Food Partners; SIG plc and May Guerney, the integrated
construction and support services company.
EiRx Therapeutics plc
EiRx Therapeutics plc ("EiRx") is a drug discovery company developing targeted therapies for cancer. The company has its own in-house
research department and has filed patents on potential new cancer drugs. EiRx is, at this stage of its development, largely pre-revenue and
as a consequence EiRx has had a number of issues relating to the sufficiency of working capital during the year.
I am therefore pleased to be able to report that in February 2008 EiRx announced the completion of a funding package which the EiRx
directors believe will give them sufficient working capital to fund the company for the next twelve months. The funding package comprised a
placing of ordinary shares and a debt for equity swap amounting to £600,000, the issue of £300,000 zero coupon non-redeemable convertible
loan stock and an increase in the company's bank facilities secured by a guarantee by one of EiRx's leading shareholders.
EiRx announced its interim results for the 6 months ended 31 December 2007 in March 2008. These results showed a reduced loss on
ordinary activities before taxation of £0.515 million (2006: loss £0.892 million) and a big improvement on the loss on ordinary activities
before taxation of £3.8 million announced for the year 30 June 2007.
In November, 2007 EiRx announced the filing of two new patent applications, which the Directors of EiRx believe demonstrates the ability
of their EnPADTM technology. This technology enables the user to focus the selection of biologically active compounds against a chosen
aspect of cell biology. EiRx believe that the EnPADTM technology is central to the future success of the company and is a central feature of
the strategic realignment from a research based model to a drug development company. Further, the EiRx directors consider that this
technology gives them a significant competitive advantage in the race to develop new cancer medicines.
Physiomics plc
Physiomics plc ("Physiomics") is a computational systems biology services company which applies simulations of cell behaviour to drug
development companies aimed at reducing the high attrition rates of clinical trials. The commercial rationale for Physiomics' services is
that at present it is estimated that the cost of bringing a new drug to market is $800 million and that 80 to 90 per cent of all clinical
drug candidates fail.
In February 2008 Physiomics announced that Billam had increased its investment in the company by the issue of £50,000 7% Loan Notes
which are repayable on demand and convertible, at Billam's option into Physiomics ordinary shares.
In March 2008 Physiomics announced its interim results for the 6 months ended 31 December, 2007 which showed a loss before taxation of
£204,000 (2006: loss before taxation of £154,000) on revenue of £55,000 (2006: revenue of £48,000). Physiomics reported that they had signed
a 3 year Memorandum of Understanding with the Institute of Life Science at Swansea University. This allows Physiomics access to the
university's IBM super computer which is dedicated to life sciences and allows computations that would normally take days to be completed in
minutes.
In September 2007 Physiomics announced a contract with the US pharmaceutical giant Eli Lilly. The directors of Physiomics believe that
this contract is a massive endorsement of their proprietary SystemCell® technology.
Unquoted Investments
TRI-MEX Group Limited
TRI-MEX Group Limited ("TRI-MEX") provides monitoring and protection solutions for the protection of vehicles and goods in transit. The
accounts for the year ended 31 March, 2007 showed a loss before taxation of £1.1 million (2006: loss before taxation of £1.24 million) on
turnover of £0.606 million (2006: turnover £0.354 million). The Group is now focussed on its "EUROWATCH" system and the group's principal
source of revenue was sales of subscriptions from this source.
In Europe 1.5 million automobiles and the cargoes of 200,000 commercial vehicles are stolen each year. TRI-MEX's EUROWATCH technology
connects all types of GPS tracking systems through to the police across Europe providing them with real time data on a vehicles location.
This has resulted in recovery rates of 100 per cent for vehicles and 90 per cent for stolen freight.
TRI-MEX has contracts with Jaguar, Land Rover and Aston Martin.
DEVELOPMENT FUNDING LIMITED
The direct result of the credit crunch has been to reduce the availability of both debt and equity, of the type offered by our wholly
owned development finance subsidiary Development Funding Limited ("DFL"), to the small and medium sized housebuilders. Set against a
background of wholesale redundancies and the dramatic slowdown in sales of new homes being announced by the housebuilding industry, which
are running at levels approximately 25 per cent lower than the levels seen in 2007, we have adopted a cautious approach to requests for new
funding.
The first development that DFL has provided mezzanine finance to is located in Northamptonshire and we have now invested a total of
£1.05 million. The development comprises 29 houses and is now substantially complete with regard to construction. I am pleased to report
that in spite of the poor conditions in the market as a whole, completions have been recorded on five houses and contracts have been
exchanged on a further two.
As previously reported DFL, are sharing the development risk with the developer on this development and despite the slower than
anticipated sales we remain confident that we will still achieve a reasonable return on this project. The financing of DFL's investment has
been provided by Billam's principal shareholder, Mr Stephen Wicks, who has made loans to the Group, on commercial terms, totalling £1.4
million at 31 December 2007. Mr Wicks has the option to convert part of his loans into ordinary shares in Billam. Whilst we are cautious as
to the short term outlook, we expect to make other development financing investments as and when suitable opportunities arise and remain
confident of the longer term prospects for DFL.
OVERHEADS
As previously reported we have made further efforts to reduce our cost base. I am therefore pleased to report that total overheads have
been reduced to just under £0.36 million for the year (2006: £0.52 million) and we will continue to do all we can to reduce costs during the
coming year.
OUTLOOK
We continue to review our remaining investments and keep a dialogue with the investee management teams on a regular basis. We will
continue to look for opportunities to make realisations from our investment portfolio, as and when we can achieve valuations that meet our
expectations. Whilst we remain cautious about the outlook for our development finance business DFL in the short term, we will look to take
advantage of the attractive opportunities that we are currently being shown in the longer term.
Simon Bennett
Chairman
30 June 2008
CONSOLIDATED INCOME STATEMENT
FOR THE YEAR ENDED 31 DECEMBER 2007
Note 2007 2006
£'000 £'000
Continuing operations
Revenue 2 363 438
Cost of sales (808) (806)
-------------------- -------------------------
-----
Gross loss (445) (368)
Administrative costs (361) (515)
-------------------- ----------------------
----- ---
Operating loss (806) (883)
Finance costs (115) (29)
Finance income 84 -
-------------------- -------------------------
-----
Loss before tax (837) (912)
Income tax expense 3 - -
-------------------- -------------------------
-----
Loss for the period (837) (912)
============== ===============
Loss per share:
Basic and diluted loss per 4 (7.89)p (8.67)p
share from total and
continuing operations
======= ===============
CONSOLIDATED BALANCE SHEET AT 31 DECEMBER 2007
______________________________________________________________________________< /fipP>
Note 2007 2006
£'000 £'000
ASSETS
Non-current assets
Financial assets at fair value 5 1,651 2,446
through profit and loss
------------------------- -------------------------
Current assets
Loans and receivables 1,026 -
Trade and other receivables 208 171
Cash and cash equivalents 5 1
------------------------- -------------------------
1,239 172
------------------------- -------------------------
Total assets 2,890 2,618
------------------------- -------------------------
LIABILITIES
Current liabilities
Trade and other payables 466 352
Short-term borrowings 1,422 353
------------------------- -------------------------
1,888 705
------------------------- -------------------------
Non-current liabilities
Long-term borrowings 299 282
Other payables - 170
------------------------- -------------------------
299 452
------------------------- -------------------------
Total liabilities 2,187 1,157
------------------------- -------------------------
Net assets 703 1,461
================ ===============
EQUITY
Share capital 6 2,279 2,279
Share premium account 5,423 5,423
Convertible loan 88 18
Merger reserve 1,012 1,012
Profit and loss account (8,099) (7,271)
------------------------- -------------------------
Total equity 703 1,461
================ ===============
CONSOLIDATED STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 DECEMBER 2007
______________________________________________________________________________< /fipP>
Share Share premium Convertible loan Merger reserve Profit and loss
Total equity
capital account
£'000 £'000 £'000 £'000 £'000
£'000
Balance at 1 January 2006 2,250 5,409 - 1,012 (6,359)
2,312
------------------- ------------------- ------------------- ------------------- ------------------
-------------------
Loss for the year - - - - (912)
(912)
------------------- ------------------- ------------------- ------------------- -------------------
-------------------
Total recognised income and - - - - (912)
(912)
expense for the year
------------------- ------------------- ------------------- ------------------- -------------------
-------------------
Issue of share capital 29 14 - - -
43
Issue of convertible loan - - - 18 - -
18
equity element
------------------- ------------------- ------------------- ------------------- -------------------
-------------------
Balance at 31 December 2006 2,279 5,423 18 1,012 (7,271)
1,461
------------------- ------------------- ------------------- ------------------- -------------------
-------------------
Loss for the year - - - - (837)
(837)
------------------- ------------------- ------------------- ------------------- -------------------
-------------------
Total recognised income and - - - - (837)
(837)
expense for the year
------------------- ------------------- ------------------- ------------------- -------------------
-------------------
Share based compensation - - - - 9
9
Issue of convertible loan - - - 70 - -
70
equity element
------------------- ----------------- ----------------- ----------------- -----------------
-----------------
Balance at 31 December 2007 2,279 5,423 88 1,012 (8,099)
703
============ =========== ========== ========== ==========
==========
CONSOLIDATED CASH FLOW STATEMENT
FOR THE YEAR ENDED 31 DECEMBER 2007
2007 2006
£'000 £'000
Cash flows from operating
activities
Loss before and after taxation (837) (912)
Adjustments for:
Fair value adjustments 580 588
Profit on sale of investments (37) (134)
Interest expense 115 29
Increase in trade and other (920) -
receivables
Decrease in trade payables (104) (197)
Interest received (84) -
Share option charge 9 -
------------------------- -------------------------
Net cash from operating (1,278) (626)
activities
------------------------- -------------------------
Cash flows from investing
activities
Purchase of investments (13) (46)
Proceeds from sale of 265 352
investment
------------------------- -------------------------
Net cash used in investing 252 306
activities
------------------------- -------------------------
Cash flows from financing
activities
Proceeds from short-term 1,134 335
borrowings
Re-payment of short term (82) (54)
borrowings
------------------------- -------------------------
Net cash used in financing 1,052 281
activities
------------------------- -------------------------
Net increase/(decrease) in 26 (39)
cash and cash equivalents
Cash and cash equivalents at (30) 9
beginning of period
------------------------- -------------------------
Cash and cash equivalents at (4) (30)
end of period
================ ==============
NOTES TO THE FINANCIAL INFORMATION
FOR THE YEAR ENDED 31 DECEMBER 2007
_________________________________________________________________________ _____
1. BASIS OF PREPARATION
The consolidated financial statements have been prepared under International Financial Reporting Standards as adopted by the EU (IFRSs).
The principal accounting policies are unchanged from those disclosed in the Company's interim financial statements for the six month period
ended 30 June 2007.
The information set out in this preliminary announcement, which does not constitute full financial statements within the meaning of s240
of the Companies Act 1985, is extracted from the audited financial statements for the Group for the year ended 31 December 2007 which:
* were approved by the directors on 30 June 2008
* carry an unqualified audit report which does not contain any statements under s237 of the Companies Act 1985
* will be posted to shareholders and available to the public shortly
* will be filed with the Registrar of Companies following the Annual General Meeting
NOTES TO THE PRELIMINARY ANNOUNCEMENT
FOR THE YEAR ENDED 31 DECEMBER 2007
_________________________________________________________________________ _____
2. income AND SEGMENTAL ANALYSIS
Billam plc is an investment company and generates income by way of management fees and profits or losses on investments. It also
generates rental income from sub letting its leasehold properties. The segmental analysis of operations is as follows:
Segmental analysis by activity
2007 2006
£'000 £'000
REVENUE BY SEGMENT
Management fees 18 11
Rental and other related income 80 75
Sale of investments 265 352
363 438
SEGMENT RESULT
Management fees 18 11
Rental and other related income (40) (14)
Losses on investment (784) (880)
Operating loss (806) (883)
Finance costs (115) (29)
Finance income 84 -
Loss before tax (837) (912)
All assets and liabilities, capital additions and depreciation are wholly attributable to investment activities.
The activity of both the investment activities and property rental arose wholly in the United Kingdom.
3. INCOME TAX EXPENSE
There is no tax credit / (charge) for either the current or prior years due to the generation of tax losses.
The Group has unrecognised deferred tax assets of £864,000 (2006: £816,000) as a result of losses carried forward of £3,084,000 (2006:
£2,720,000).
4. LOSS PER ORDINARY SHARE
The loss per ordinary share is based on the weighted average number of ordinary shares in issue during the year of 10,603,835 ordinary
shares of 20 pence (2006: 10,524,035 ordinary shares of 20 pence) and the following figures:
2007 2006
£'000 £'000
Loss attributable to equity shareholders (837) (912)
Loss per ordinary shares (7.89)p (8.67)p
Diluted earnings per share is taken as equal to basic earnings per share as the Group has recorded a loss and therefore the effect of
including share options is anti-dilutive.
5. INVESTMENTS
2007 2006
£'000 £'000
Investments listed on a recognised investment exchange 1,025 1,087
Other unlisted investments 626 1,359
1,651 2,446
Listed Listed Unlisted Total
overse investme
as nts
£'000 £'000 £'000 £'000
Cost
At 1 January 2006 745 82 5,036 5,863
Additions - - 46 46
Sales
- proceeds (174) (150) (28) (352)
- realised gains/(losses) on sales 105 68 (39) 134
At 31 December 2006 676 - 5,015 5,691
Unrealised appreciation / (depreciation)
At 1 January 2006 638 140 (3,435) (2,657)
(Decrease)/increase in unrealised appreciation/(depreciation) (227) (140) (221) (588)
At 31 December 2006 411 - (3,656) (3,245)
Cost or valuation
At 31 December 2006 1,087 - 1,359 2,446
At 31 December 2005 1,383 222 1,601 3,206
5. INVESTMENTS (CONTINUED)
Listed Unlisted Total
investme
nts
£'000 £'000 £'000
Cost
At 1 January 2007 676 5,015 5,691
Additions 13 - 13
Sales
- proceeds (115) (150) (265)
- realised gains/(losses) on sales - 37 37
At 31 December 2007 574 4,902 5,476
Unrealised appreciation / (depreciation)
At 1 January 2007 411 (3,656) (3,245)
Increase/(decrease) in unrealised appreciation/(depreciation) 40 (620) (580)
At 31 December 2007 451 (4,276) (3,825)
Cost or valuation
At 31 December 2007 1,025 626 1,651
At 31 December 2006 1,087 1,359 2,446
2007 2006
£'000 £'000
Net gains on sales 37 134
Net decrease in unrealised depreciation (580) (588)
Loss on investments (543) (454)
6. SHARE CAPITAL
2007 2006
£'000 £'000
Authorised
19,210,250 ordinary shares of 20p each 3,842 3,842
(2006: 19,210,250 ordinary shares of 20p
each)
157,950,000 deferred shares of 0.1p each 158 158
4,000 4,000
Allotted, called up and fully paid
10,603,835 ordinary shares of 20p each 2,121 2,121
(2006: 10,603,835 ordinary shares of 20p
each)
157,950,000 deferred shares of 0.1p each 158 158
2,279 2,279
6. SHARE CAPITAL (CONTINUED)
The Group operates an unapproved share option scheme. Awards under each scheme are made periodically to employees
The Group has used the Black-Scholes-Merton formula to calculate the fair value of outstanding options and deferred shares. The
assumptions applied to the Black-Scholes-Merton formula for share options issued and the fair value per option are as follows:
Share options
Expected life of options based on options exercised to date 4 years
Volatility of share price 41%
Dividend yield 0%
Risk free interest rate 5.62%
Share price at date of grant 15p
Exercise price 20p
Fair value per option £0.03
The charge calculated up to 31 December 2007 is £9,000 (2006: £Nil).
Volatility was assessed over the period since the shares were listed.
A reconciliation of option movements over the year ended 31 December 2007 is shown below:
Number Exercise price
Granted in the year 1,900,000 20p
Outstanding at 31 December 2007 1,900,000
Exercisable at 31 December 2007 -
at 31 December 2007 outstanding options granted over 20p ordinary shares were as follows:
Share option scheme Exercise price Number Dates exercisable
Company unapproved 20p 1,900,000 24 March 2010 to
23 March 2017
There were no share options in issue in the prior year.
7. TRANSACTIONS WITH RELATED PARTIES
Within creditors is an amount accrued but not yet paid to former director A G P Forrest in relation to remuneration amounting to
£118,000 (2006: £377,000). This amount is to be repaid in two half yearly instalments. Included in creditors is also an amount due to Mr N
Malde of £50,000 in respect of unpaid remuneration.
During the year, a major shareholder, Mr S D Wicks advanced monies to the Group and the fair value of the outstanding balance at the
year end was £1,413,000. Interest accrued during the year at 1% above base rates amounted to £60,000 and this remained outstanding at the
year end. Interest of £7,000 relating to previous years also remains outstanding at the year end. The loan was secured by way of a debenture
over the Company's assets. Whilst there are no formal terms of repayment, Mr S D Wicks has agreed not to seek repayment for a period of at
least 12 months from the date of approval of these accounts unless the Group has funds to do so, albeit he may exercise his option to
convert part or all of these loans into shares during that time.
Following the year end Highlands Village Limited, a company in which Mr S D Wicks and Mr N Malde are both directors and shareholders,
has advanced £285,000 to the Company on an unsecured basis at 1% above base rates.
This information is provided by RNS
The company news service from the London Stock Exchange
END
FR SDDFDSSASEIM
1 Year Billam Chart |
1 Month Billam Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
